Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 148 No. 1920 (2018)

Accidental or intentional exposure to potentially toxic medications, natural toxins and chemicals during pregnancy: analysis of data from Tox Info Suisse

  • Tabea Vogel
  • Saskia Lüde
  • Rahel Baumgartner
  • Christine Rauber-Lüthy
  • Ana Paula Simões-Wüst
DOI
https://doi.org/10.4414/smw.2018.14620
Cite this as:
Swiss Med Wkly. 2018;148:w14620
Published
16.05.2018

Summary

OBJECTIVE

Affected women and health professionals are still often unsure about how to react to exposures to potentially harmful agents during pregnancy. We wanted to find out which agents worry both pregnant women and professionals, under what circumstances the exposures take place, how they are currently dealt with and how serious they are.

METHODS

Making use of the archives of Tox Info Suisse, the foundation that provides poisons information in Switzerland both for members of the general public and for healthcare professionals, we set up an analysis of exposures to possibly harmful agents during pregnancy. Queries during pregnancy between 1995 and 2015 were analysed. Demographic information, exposure and agent characteristics as well as – in a subgroup of cases – the corresponding treatments were considered in the present descriptive, retrospective analysis.

RESULTS

Over the 21-year period, 2871 exposures during pregnancy were identified. The majority of the calls were made by members of the general public (2035, 70.9%; most often by the affected women themselves), followed by physicians (733, 25.5%). General public queries were mostly due to exposures connected with household chemicals (675/2035, 33.2%); those of physicians were most often due to medications (415/733, 56.6%). The majority of agent exposures occurred accidentally at home, at work, outdoors or at various other places (2297/2871, 80.0%). Less frequently, the exposures were intentional and had a suicidal, abusive, criminal or other character (471/2871, 16.4%). Of the 2871 calls, 905 cases with symptoms were recorded. Of the 1268 symptoms, 820 were mild (64.7%), 144 moderate (11.3%), 24 severe (1.9%, including 12 abortions) and 280 were not further specified (22.1%). In 1867 cases (65%), a total of 2331 measures were recommended by Tox Info Suisse, 1961 thereof to be carried out immediately. The two most common immediate measures were exposure interruption (412/1961, 21.0%) and forwarding to another institution (345/1961, 17.6%). In 70 cases, physicians’ follow-up reports could be analysed; paracetamol was the agent most frequently involved (15 cases), followed by mefenamic acid (9) and the household product sodium hypochlorite (9).

CONCLUSIONS

Tox Info Suisse recorded an average of 137 cases of agent exposure during pregnancy per year, mostly due to accidents with household products. Suicidal intentions played a role in a considerable number of exposures. Measures are needed to prevent accidental exposure of pregnant women to toxic substances and to support them in this exceptional life period.

References

  1. Zaki NM, Albarraq AA. Use, attitudes and knowledge of medications among pregnant women: A Saudi study. Saudi Pharm J. 2014;22(5):419–28. doi:.https://doi.org/10.1016/j.jsps.2013.09.001
  2. Rasmussen SA. Human teratogens update 2011: can we ensure safety during pregnancy? Birth Defects Res A Clin Mol Teratol. 2012;94(3):123–8. doi:.https://doi.org/10.1002/bdra.22887
  3. Barrow MV. A brief history of teratology to the early 20th century. Teratology. 1971;4(2):119–29. doi:.https://doi.org/10.1002/tera.1420040202
  4. Czeizel AE, Tomcsik M, Tímár L. Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynecol. 1997;90(2):195–201. doi:.https://doi.org/10.1016/S0029-7844(97)00216-0
  5. Czeizel AE, Gidai J, Petik D, Timmermann G, Puhó EH. Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health. 2008;24(1-2):11–28. doi:.https://doi.org/10.1177/0748233708089020
  6. Czeizel A, Szentesi I, Szekeres I, Molnár G, Glauber A, Bucski P. A study of adverse effects on the progeny after intoxication during pregnancy. Arch Toxicol. 1988;62(1):1–7. doi:.https://doi.org/10.1007/BF00316249
  7. Gunnarskog J, Källén AJ. Drug intoxication during pregnancy: a study with central registries. Reprod Toxicol. 1993;7(2):117–21. doi:.https://doi.org/10.1016/0890-6238(93)90245-3
  8. Flint C, Larsen H, Nielsen GL, Olsen J, Sørensen HT. Pregnancy outcome after suicide attempt by drug use: a Danish population-based study. Acta Obstet Gynecol Scand. 2002;81(6):516–22. doi:.https://doi.org/10.1034/j.1600-0412.2002.810607.x
  9. Schaefer C, Hoffmann-Walbeck P. Intoxikationen bei Schwangeren [Poisonings in pregnancy]. Med Klin Intensivmed Notf Med. 2012;107(2):118–22. Article in German.
  10. Nordeng H, Ystrøm E, Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur J Clin Pharmacol. 2010;66(2):207–14. doi:.https://doi.org/10.1007/s00228-009-0744-2
  11. Gils C, Pottegård A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16(1):226. doi:.https://doi.org/10.1186/s12884-016-1025-6
  12. Persson HE, Sjöberg GK, Haines JA, de Garbino JP. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36(3):205–13. doi:.https://doi.org/10.3109/15563659809028940
  13. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. 2017. Available from https://www.whocc.no/atc_ddd_index/.
  14. FMH Swiss Medical Association. Grundlagen der Behandlung von Patientinnen und Patienten: 4.1 Behandlungsvertrag zwischen Arzt und Patient. 2017. Available from http://www.fmh.ch/files/pdf11/Patientenbehandlung_D1.pdf.
  15. Gils C, Pottegård A, Ennis ZN, Damkier P. Perception of drug teratogenicity among general practitioners and specialists in obstetrics/gynecology: a regional and national questionnaire-based survey. BMC Pregnancy Childbirth. 2016;16(1):226. doi:.https://doi.org/10.1186/s12884-016-1025-6
  16. Schaefer C, Spielmann H, Vetter K, Weber-Schöndorfer C. Arzneimittel in Schwangerschaft und Stillzeit (8 ed.). München: Urban and Fischer 2012.
  17. Sein Anand J, Chodorowski Z, Ciechanowicz R, Klimaszyk D, Lukasik-Głebocka M. Acute suicidal self-poisonings during pregnancy. Przegl Lek. 2005;62(6):434–5.
  18. Lester D. The timing of attempted suicide during pregnancy. Acta Paediatr Acad Sci Hung. 1987;28(3-4):259–60.
  19. Oates M. Suicide: the leading cause of maternal death. Br J Psychiatry. 2003;183(4):279–81. doi:.https://doi.org/10.1192/bjp.183.4.279
  20. Czeizel AE. Attempted suicide and pregnancy. J Inj Violence Res. 2011;3(1):45–54. doi:.https://doi.org/10.5249/jivr.v3i1.77
  21. Czeizel AE, Gidai J, Petik D, Timmermann G, Puhó EH. Self-poisoning during pregnancy as a model for teratogenic risk estimation of drugs. Toxicol Ind Health. 2008;24(1-2):11–28. doi:.https://doi.org/10.1177/0748233708089020
  22. Marzuk PM, Tardiff K, Leon AC, Hirsch CS, Portera L, Hartwell N, et al. Lower risk of suicide during pregnancy. Am J Psychiatry. 1997;154(1):122–3. doi:.https://doi.org/10.1176/ajp.154.1.122
  23. Berger A, Bachmann N, Signorell A, Erdin R, Oelhafen S, Reich O, et al. Perinatal mental disorders in Switzerland: prevalence estimates and use of mental-health services. Swiss Med Wkly. 2017;147:w14417. doi:.https://doi.org/10.4414/smw.2017.14417
  24. Levy G. Gastrointestinal clearance of drugs with activated charcoal. N Engl J Med. 1982;307(11):676–8. doi:.https://doi.org/10.1056/NEJM198209093071109
  25. Lockwood CJ. Pathogenesis of spontaneous preterm birth In S. M. Ramin (Ed.), UpToDate®. In V. A. Barss (Series Ed.). www.uptodate.com. Retrieved from www.uptodate.com. 2014

Most read articles by the same author(s)